52 related articles for article (PubMed ID: 1907259)
1. Manganese dipyridoxyl diphosphate. Effect of dose, time, and pulse sequence on hepatic enhancement in rats.
Nelson RC; Chezmar JL; Newberry LB; Malko JA; Gedgaudas-McClees RK; Bernardino ME
Invest Radiol; 1991 Jun; 26(6):569-73. PubMed ID: 1907259
[TBL] [Abstract][Full Text] [Related]
2. MnDPDP as a negative hepatic contrast agent: evaluation of STIR imaging compared with T1-weighted SE and GE techniques.
Halavaara JT; Lamminen AE
J Comput Assist Tomogr; 1997; 21(1):94-9. PubMed ID: 9022776
[TBL] [Abstract][Full Text] [Related]
3. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part II: comparison with cine magnetic resonance imaging.
Yang DH; Kim TH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Lim TH
Invest Radiol; 2005 Jan; 40(1):56-61. PubMed ID: 15597021
[TBL] [Abstract][Full Text] [Related]
4. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary MR imaging: first human experience with MnDPDP.
Lim KO; Stark DD; Leese PT; Pfefferbaum A; Rocklage SM; Quay SC
Radiology; 1991 Jan; 178(1):79-82. PubMed ID: 1898539
[TBL] [Abstract][Full Text] [Related]
6. [Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
Gehl HB; Günther RW; Klever P; Hauptmann S
Rofo; 1993 Sep; 159(3):240-4. PubMed ID: 8397012
[TBL] [Abstract][Full Text] [Related]
7. T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
Zuo CS; Seoane P; Lanigan T; Harnish P; Prasad PV; Storey P; Li W; Rofsky NM
J Magn Reson Imaging; 2002 Dec; 16(6):668-75. PubMed ID: 12451580
[TBL] [Abstract][Full Text] [Related]
8. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part I: comparison with pathologic examination.
Kim TH; Yang DH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Gong GY; Lim TH
Invest Radiol; 2005 Jan; 40(1):49-55. PubMed ID: 15597020
[TBL] [Abstract][Full Text] [Related]
9. Relaxation enhancing properties of MnDPDP in human myocardium.
Skjold A; Vangberg TR; Kristoffersen A; Haraldseth O; Jynge P; Larsson HB
J Magn Reson Imaging; 2004 Dec; 20(6):948-52. PubMed ID: 15558550
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of a T1-weighted inversion-recovery-, gradient-echo- and spin-echo sequence for imaging of the brain at 3.0 Tesla].
Stehling C; Niederstadt T; Krämer S; Kugel H; Schwindt W; Heindel W; Bachmann R
Rofo; 2005 Apr; 177(4):536-42. PubMed ID: 15838759
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.
Elizondo G; Fretz CJ; Stark DD; Rocklage SM; Quay SC; Worah D; Tsang YM; Chen MC; Ferrucci JT
Radiology; 1991 Jan; 178(1):73-8. PubMed ID: 1898538
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
Pui MH; Goh PS; Choo HF; Fok EC
Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
[TBL] [Abstract][Full Text] [Related]
13. Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
Skjold A; Amundsen BH; Wiseth R; Støylen A; Haraldseth O; Larsson HB; Jynge P
J Magn Reson Imaging; 2007 Sep; 26(3):720-7. PubMed ID: 17729351
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
Guo T; Zhang XL; Chang RM; Zhang YZ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):946-8. PubMed ID: 13129729
[TBL] [Abstract][Full Text] [Related]
15. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
16. An apparent unidirectional influx constant for manganese as a measure of myocardial calcium channel activity.
Skjold A; Kristoffersen A; Vangberg TR; Haraldseth O; Jynge P; Larsson HB
J Magn Reson Imaging; 2006 Nov; 24(5):1047-55. PubMed ID: 17024667
[TBL] [Abstract][Full Text] [Related]
17. Renal corticomedullary junction. Performance of T1-weighted MR pulse sequences.
Baumgartner BR; Nelson RC; Torres WE; Malko JA; Peterson JE; Bernardino ME
Invest Radiol; 1989 Nov; 24(11):884-7. PubMed ID: 2807803
[TBL] [Abstract][Full Text] [Related]
18. Importance of T2*-weighted gradient-echo MRI for diagnosis of cortical vein thrombosis.
Fellner FA; Fellner C; Aichner FT; Mölzer G
Eur J Radiol; 2005 Nov; 56(2):235-9. PubMed ID: 15967621
[TBL] [Abstract][Full Text] [Related]
19. Axon tracing in the adult rat optic nerve and tract after intravitreal injection of MnDPDP using a semiautomatic segmentation technique.
Olsen Ø; Thuen M; Berry M; Kovalev V; Petrou M; Goa PE; Sandvig A; Haraldseth O; Brekken C
J Magn Reson Imaging; 2008 Jan; 27(1):34-42. PubMed ID: 18157895
[TBL] [Abstract][Full Text] [Related]
20. Pulse sequence optimization for MR imaging using a paramagnetic hepatobiliary contrast agent.
Greif WL; Buxton RB; Lauffer RB; Saini S; Stark DD; Wedeen VJ; Rosen BR; Brady TJ
Radiology; 1985 Nov; 157(2):461-6. PubMed ID: 4048456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
